New Company Excellergy Aims to Start First Human Trials Soon
Excellergy, a new company in the pharmaceutical field, has recently raised $70 million in its first major funding round. This […]
New AI Tool Helps Predict Lung Disease Outcomes
A new AI tool called Vascul8 has been proven to help in the treatment of lung vascular disorders, according to
New Hope for Early Alzheimer’s Treatment: ACI-35.030 Shows Promise
AC Immune SA has shared exciting news from their tests of two new treatments for early Alzheimer’s disease. These treatments,
Important Updates from Medicare, FDA, and Biotech Companies
Today, we have some important news from Medicare, the Food and Drug Administration (FDA), and updates from several biotech companies
Pharmaceutical News
New Reporter Joins Our Health News Team
We’re pleased to welcome Annabel Kartal-Allen to our team. She writes for our health and medicine news sites. Annabel is
Takeda to Stop Research on Cell Therapy, Shift Focus to Other Treatments
Takeda, a big Japanese drug company, has decided to stop its research on cell therapy. This is a type of
Rocket Pharmaceuticals Stops Development of Gene Therapy for Rare Blood Disorder
Rocket Pharmaceuticals has decided to stop developing a gene therapy treatment for a rare blood disorder called Fanconi anaemia. This
Pharmaceutical News
Latest Updates in Drug Manufacturing: Symbiosis, BioGrad, Abzena, Eschbach, and More
In this update, we cover news about making sterile drugs, producing biological treatments, developing cell lines, and creating radiopharmaceuticals. Symbiosis,
Xoma Acquires Struggling Cancer Drug Company Mural Oncology, Plans to Shut It Down
Xoma Royalty Corp. has agreed to buy Mural Oncology, a biotech company focused on cancer treatments, for $2.035 per share.
Pharmaceutical Companies Face Major Challenges as Cancer Drug Patents Expire Soon
Over the next five years, many top-selling cancer drugs from major pharmaceutical companies will lose their patent protection. This is